Form 8-K CYTOKINETICS INC For: Dec 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Cytokinetics (CYTK) PT Raised to $48 at JMP Securities
December 20, 2021 2:05 PM ESTJMP Securities analyst Jason Butler raised the price target on Cytokinetics (NASDAQ: CYTK) to $48.00 (from $44.00) while maintaining a Market Outperform rating on the expanding Ji Xing cardiovascular partnership.
... More